Methanandamide blocks amphetamine-induced behavioral sensitization in rats

European Journal of Pharmacology

Volumn 627, Issue 1-3, 2010, Pages 150-155

  Rasmussen, Bruce A ^a   Unterwald, Ellen M ^b,c   Kim, Jae K ^a   Rawls, Scott M ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Amphetamine; Anandamide; Cannabinoid; Locomotor; Metahanandamide; Psychostimulant; Sensitization; Stereotypy; Vanilloid

Indexed keywords

AMPHETAMINE; METHANANDAMIDE; PSYCHOSTIMULANT AGENT;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SENSITIZATION;

AMPHETAMINE; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; INJECTIONS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 73449128260     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.10.059     Document Type: Article

References (57)

1. Arnold J.C. The role of endocannabinoid transmission in cocaine addiction. Pharmacol. Biochem. Behav. 81 (2005) 396-406
2. Arnold J.C., Topple A.N., Hunt G.E., and McGregor I.S. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55, 940 on behavioral sensitization to cocaine. Eur. J. Pharmacol. 354 (1998) 9-16
3. Baranowska U., Göthert M., Rudz R., and Malinowska B. Methanandamide allosterically inhibits in vivo the function of peripheral nicotinic acetylcholine receptors containing the alpha 7-subunit. J. Pharmacol. Exp. Ther. 326 (2008) 912-919
4. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 20 (2001) 7033-7040
5. Childers S.R., Pacheco M.A., Bennett B.A., Edwards T.A., Hampson R.E., Mu J., and Deadwyler S.A. Cannabinoid receptors: G-protein-mediated signal transduction mechanisms. Biochem. Soc. Symp. 59 (1993) 27-50
6. Christie B.R., Schexnayder L.K., and Johnston D. Contribution of voltage-gated Ca2+ channels to homosynaptic long-term depression in the CA1 region in vitro. J. Neurophysiol. 77 (1997) 1651-1655
7. Corbillé A.G., Valjent E., Marsicano G., Ledent C., Lutz B., Hervé D., and Girault J.A. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. J. Neurosci. 27 (2007) 6937-6947
8. Creese I., and Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83 (1975) 419-436
9. de Rover M., Mansvelder H.D., Lodder J.C., Wardeh G., Schoffelmeer A.N., and Brussaard A.B. Long-lasting nicotinic modulation of GABAergic synaptic transmission in the rat nucleus accumbens associated with behavioural sensitization to amphetamine. Eur. J. Neurosci. 19 (2004) 2859-2870
10. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
11. Di Marzo V., Bisogno T., and De Petrocellis L. Anandamide: some like it hot. Trends Pharmacol. Sci. 22 (2001) 346-349
12. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., and Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7656-7660
13. Ferrari F., Ottani A., and Giuliani D. Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat. Life Sci. 65 (1999) 823-831
14. Filip M., Gołda A., Zaniewska M., McCreary A.C., Nowak E., Kolasiewicz W., and Przegaliński E. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol. Rep. 58 (2006) 806-819
15. Fride E., and Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231 (2006) 313-314
16. Hejazi N., Zhou C., Oz M., Sun H., Ye J.H., and Zhang L. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol. Pharmacol. 69 (2006) 991-997
17. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547 (1991) 267-274
18. Järbe T.U., DiPatrizio N.V., Li C., and Makriyannis A. The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats. Pharmacol. Biochem. Behav. 75 (2003) 809-821
19. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16 (1991) 223-244
20. Kauer J.A., and Malenka R.C. Synaptic plasticity and addiction. Nat. Rev., Neurosci. 8 (2007) 844-858
21. Kelly P.H., Seviour P.W., and Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94 (1975) 507-522
22. Lee J., Di Marzo V., and Brotchie J.M. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Neuropharmacology 51 (2006) 557-565
23. Lesscher H.M., Hoogveld E., Burbach J.P., van Ree J.M., and Gerrits M.A. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol. 15 (2005) 31-37
24. Lozovaya N., Yatsenko N., Beketov A., Tsintsadze T., and Burnashev N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J. Neurosci. 25 (2005) 7499-7506
25. Maingret F., Patel A.J., Lazdunski M., and Honoré E. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J. 20 (2001) 47-54
26. Malinowska B., Kwolek G., and Göthert M. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedeberg's Arch. Pharmacol. 364 (2001) 562-569
27. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359 (1998) 1-18
28. Mezey E., Tóth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., and Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3655-3660
29. Moss D.E., Koob G.F., McMaster S.B., and Janowsky D.S. Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors. Pharmacol. Biochem. Behav. 21 (1984) 641-644
30. Muschamp J.W., and Siviv S.M. Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55, 212-2 in Lewis rats. Pharmacol. Biochem. Behav. 73 (2002) 835-842
31. Narendran R., and Martinez D. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse 62 (2008) 851-869
32. Nicholson R.A., Liao C., Zheng J., David L.S., Coyne L., Errington A.C., Singh G., and Lees G. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res. 978 (2003) 194-204
33. Oz M., Zhang L., Ravindran A., Morales M., and Lupica C.R. Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J. Pharmacol. Exp. Ther. 310 (2004) 1152-1160
34. Oz M., Tchugunova Y., and Dinc M. Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur. J. Pharmacol. 502 (2006) 47-58
35. Paulson P.E., and Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19 (1995) 56-65
36. Paulson P.E., Camp D.M., and Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology(Berl) 103 (1991) 480-492
37. Pearlman R.J., Aubrey K.R., and Vandenberg R.J. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. J. Neurochem. 84 (2003) 592-601
38. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74 (1997) 129-180
39. Przegaliński E., Siwanowicz J., and Chojnacka-Wójcik E. Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice. Pol. J. Pharmacol. 51 (1999) 385-390
40. Przegaliński E., Göthert M., Frankowska M., and Filip M. WIN 55, 212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function. Eur. J. Pharmacol. 517 (2005) 68-73
41. Rasmussen B.A., Kim E., Unterwald E.M., and Rawls S.M. Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism. Brain Res. 1260 (2009) 7-14
42. Roberts L.A., Ross H.R., and Connor M. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology 54 (2008) 172-180
43. Robinson T.E., and Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85 (1982) 253-254
44. Robinson T.E., and Camp D.M. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol. Biochem. Behav. 26 (1987) 821-827
45. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
46. Robinson T.E., Browman K.E., Crombag H.S., and Badiani A. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci. Biobehav. Rev. 22 (1998) 347-354
47. Romero J., García L., Cebeira M., Zadrozny D., Fernández-Ruiz J.J., and Ramos J.A. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci. 56 (1995) 2033-2040
48. Romero J., García-Palomero E., Lin S.Y., Ramos J.A., Makriyannis A., and Fernández-Ruiz J.J. Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sci. 58 (1996) 1249-1257
49. Schoffelmeer A.N., De Vries T.J., Wardeh G., van de Ven H.W., and Vanderschuren L.J. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J. Neurosci. 22 (2002) 3269-3276
50. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 639-677
51. Soderman A.R., and Unterwald E.M. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience 154 (2008) 1506-1516
52. Thiemann G., Di Marzo V., Molleman A., and Hasenöhrl R.U. The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus. Pharmacol. Biochem. Behav. 89 (2008) 384-391
53. Thiemann G., van der Stelt M., Petrosino S., Molleman A., Di Marzo V., and Hasenöhrl R.U. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. Behav. Brain Res. 187 (2008) 289-296
54. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
55. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 27 (2004) 827-839
56. Wenger T., Moldrich G., and Furst S. Neuromorphological background of cannabis addiction. Brain Res. Bull. 61 (2003) 125-128
57. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sørgård M., Di Marzo V., Julius D., and Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457